Kayoko Saito

13.1k total citations · 2 hit papers
230 papers, 4.2k citations indexed

About

Kayoko Saito is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Kayoko Saito has authored 230 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 77 papers in Genetics and 44 papers in Surgery. Recurrent topics in Kayoko Saito's work include Neurogenetic and Muscular Disorders Research (71 papers), Muscle Physiology and Disorders (52 papers) and RNA modifications and cancer (51 papers). Kayoko Saito is often cited by papers focused on Neurogenetic and Muscular Disorders Research (71 papers), Muscle Physiology and Disorders (52 papers) and RNA modifications and cancer (51 papers). Kayoko Saito collaborates with scholars based in Japan, United States and United Kingdom. Kayoko Saito's co-authors include Makiko Ōsawa, Tatsushi Toda, Eri Kondo-Iida, Yukio Fukuyama, Kazuhiro Kobayashi, Ichiro Kanazawa, Mieko Yoshioka, Yutaka Nakahori, Yasuo Nakagome and Masashi Miyake and has published in prestigious journals such as Nature, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Kayoko Saito

220 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy

1998 624 citations Kiichiro Matsumura, Eri Kondo-Iida et al. profile →
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

2022 168 citations Michelle A. Farrar, Francesco Muntoni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kayoko Saito Japan	30	2.4k	1.0k	722	614	497	230	4.2k
Xuri Li China	40	3.6k 1.5×	415 0.4×	605 0.8×	533 0.9×	370 0.7×	121	6.8k
Beril Talim Türkiye	31	3.0k 1.3×	487 0.5×	444 0.6×	580 0.9×	405 0.8×	138	4.0k
Hiromi Nishimura Japan	28	1.9k 0.8×	779 0.8×	945 1.3×	168 0.3×	309 0.6×	86	3.9k
Hung Li Taiwan	43	3.9k 1.6×	2.4k 2.4×	889 1.2×	587 1.0×	863 1.7×	88	6.1k
Simón Méndez‐Ferrer United Kingdom	37	2.4k 1.0×	2.8k 2.8×	749 1.0×	421 0.7×	306 0.6×	77	8.3k
Anthony Béhin France	33	1.6k 0.7×	773 0.8×	318 0.4×	560 0.9×	141 0.3×	145	3.9k
Motohiko Sato Japan	36	5.0k 2.1×	412 0.4×	599 0.8×	523 0.9×	886 1.8×	138	7.6k
Charles Keller United States	36	4.3k 1.8×	733 0.7×	814 1.1×	314 0.5×	699 1.4×	148	6.6k
Cong Yu China	26	1.2k 0.5×	647 0.6×	898 1.2×	126 0.2×	264 0.5×	99	4.7k
Raphaël Guzman Switzerland	45	1.5k 0.6×	1.2k 1.2×	1.1k 1.5×	1.1k 1.8×	579 1.2×	288	7.2k

Countries citing papers authored by Kayoko Saito

Since Specialization

Citations

This map shows the geographic impact of Kayoko Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayoko Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayoko Saito more than expected).

Fields of papers citing papers by Kayoko Saito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayoko Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayoko Saito. The network helps show where Kayoko Saito may publish in the future.

Co-authorship network of co-authors of Kayoko Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Kayoko Saito. A scholar is included among the top collaborators of Kayoko Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayoko Saito. Kayoko Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Proud, Crystal M., Elizabeth Kichula, Ashutosh Kumar, et al.. (2025). Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations. Journal of Neuromuscular Diseases. 708698394–708698394.

Servais, Laurent, John Day, Darryl C. De Vivo, et al.. (2024). Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry. Journal of Neuromuscular Diseases. 11(2). 425–442. 27 indexed citations

Tizzano, Eduardo F., Susana Quijano-Roy, Laurent Servais, et al.. (2024). Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec. European Journal of Paediatric Neurology. 53. 18–24.

Oskoui, Maryam, Nicolas Deconinck, Elena Mazzone, et al.. (2023). Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA). Journal of the Neurological Sciences. 455. 121096–121096. 2 indexed citations

Ishizaki, Yuko, et al.. (2022). Factors Surrounding the Healthcare Transition From Pediatric to Adult Care in 5p- Syndrome: A Survey Among Healthcare Professionals. Frontiers in Pediatrics. 10. 924343–924343. 1 indexed citations

Tsuchihashi, Yuuki, Takuya Yamagishi, Motoi Suzuki, et al.. (2021). High attack rate of SARS-CoV-2 infections during a bus tour in Japan. Journal of Travel Medicine. 28(8). 10 indexed citations

Finkel, Richard S., John Day, Darryl C. De Vivo, et al.. (2020). RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design. Journal of Neuromuscular Diseases. 7(2). 145–152. 26 indexed citations

Servais, Laurent, John Day, Darryl C. De Vivo, et al.. (2020). Real-World Treatment Patterns and Outcomes in Patients with Spinal Muscular Atrophy Collected from the RESTORE Registry (2470). Neurology. 94(15_supplement).

Kirschner, Janbernd, Eugenio Mercuri, Richard S. Finkel, et al.. (2017). Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study. Neuropediatrics. 48.

10.

Ishiura, Hiroyuki, Yuji Takahashi, Toshihiro Hayashi, et al.. (2014). Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. Journal of Human Genetics. 59(3). 163–172. 49 indexed citations

11.

Saito, Kayoko, Hiroki Goto, & O. Ichinokura. (2012). Segment type DC Excited Reluctance Generator. 392. 2 indexed citations

12.

Iguchi, Masahiro, Akihiro Hashiguchi, Eiichi Ito, et al.. (2012). Charcot‐marie‐tooth disease type 4C in Japan: Report of a case. Muscle & Nerve. 47(2). 283–286. 3 indexed citations

13.

Takahashi, Yumi, Kana Hosoki, Masafumi Matsushita, et al.. (2011). A loss‐of‐function mutation in the SLC9A6 gene causes X‐linked mental retardation resembling Angelman syndrome. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 156(7). 799–807. 29 indexed citations

14.

Ito, Yasushi, Noriyuki Shibata, Kayoko Saito, Makio Kobayashi, & Makiko Ōsawa. (2010). New insights into the pathogenesis of spinal muscular atrophy. Brain and Development. 33(4). 321–331. 16 indexed citations

15.

Kajiwara, Koji, Kayoko Saito, Kenichi Yoshikawa, et al.. (2005). Image-Guided Stereotactic Radiosurgery with the CyberKnife for Pituitary Adenomas. min - Minimally Invasive Neurosurgery. 48(2). 91–96. 52 indexed citations

16.

Tachi, Nobutada, Shunzo Chiba, Masafumi Matsuo, Kiichiro Matsumura, & Kayoko Saito. (2001). Fukuyama muscular dystrophy associated with lack of C-terminal domain of dystrophin. Pediatric Neurology. 24(5). 373–378. 1 indexed citations

17.

Hirasawa, Kyoko, Noriko Suzuki, Haruko Suzuki, et al.. (2000). Transient Exacerbation of Muscle Weakness Induced by Febrile Illness in Patients with Congenital Muscular Dystrophy(Papers for Cerebrating the Fifth Aniversary of the Directorship of Prof. M. Osawa at the Department of Pediatrics, Tokyo Women's Medical University). 70(1). 1 indexed citations

18.

Saito, Kayoko, Yukio Fukuyama, Eri Kondo-Iida, et al.. (1999). Congenital muscular dystrophy with central and peripheral nervous system involvement in a Belgian patient. Neuromuscular Disorders. 9(4). 251–256. 7 indexed citations

19.

Saito, Kayoko, Makiko Ōsawa, Yukio Fukuyama, et al.. (1998). CLINICAL FEATURES AND MOLECULAR GENETIC DIAGNOSIS OF PROXIMAL SPINAL MUSCULAR ATROPHY IN CHILDHOOD. 68(3). 93–107. 4 indexed citations

20.

Saito, Kayoko, et al.. (1996). Clinico-ECoG correlate of megimide-induced epileptic seizures in epilepsy-prone El and its mother strain nonepileptic ddY mice. Physiology & Behavior. 60(3). 809–816. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact